-
Formula of Miller et al for Normal Range Westergren ESR for Age and Gender
-
Correction of ESR to a Hematocrit of 40%
-
Factors That Can Affect the Erythrocyte Sedimentation Rate (ESR)
-
Simplified Method of Pawlotsky et al for the Sigma ESR
-
Nomogram of Manely for Correcting the Erythrocyte Sedimentation Rate (ESR) Based on Room Temperature
-
Mentzer Formula
-
England-Fraser Formula
-
Shine-Lal Formula
-
M / H Ratio
-
RDW * HDW
-
MCV / MCH Ratio
-
MCH / RBC Ratio
-
RDW / RBC Ratio
-
Green and King Formula
-
Discriminant Functions of Eldibany et al for Diagnosing Microcytic Anemias
-
Calculating the Total Iron Replacement Dose in Iron Deficiency Anemia
-
Criteria for the Primary Defective Iron-Reutilization Syndrome
-
Amount of Iron Lost Through a Known Blood Loss with an Estimate for the Replacement Dose
-
Clinical Response to Adequate Iron Replacement
-
Indications for Intravenous Iron Replacement with Iron Dextran
-
Equation of Witte et al for Predicting Iron Deficiency from Serum Ferritin and the Erythrocyte Sedimentation Rate (ESR)
-
Algorithm of Mulherin et al for the Diagnosis of Iron Deficiency Anemia vs Anemia of Chronic Disease in a Patient with Rheumatoid Arthritis
-
Use of Soluble Serum Transferrin Receptor to Evaluate an Anemic Patient with a Low Serum Iron Level
-
Stages of Iron Depletion and Deficiency
-
Clinical Findings in Iron Deficiency Not Associated with Anemia
-
Scoring System of Casanova et al for Identifying Iron Deficiency Anemia in a Pregnant Woman
-
Staging Iron Deficiency Using the Concentration of Zinc Protoporphyrin
-
Protocol of Heming et al for Identifying Iron Deficiency Anemia in a Critically Ill Patient
-
Hereditary Atransferrinemia with Iron Overload and Microcytic Anemia
-
Iron-Refractory Iron Deficiency Anemia (IRIDA) Associated with a Mutation in TMPRSS6
-
Corrected Absolute Reticulocyte Count from RBC Count
-
Corrected Reticulocyte Count for Hct (Reticulocyte Index)
-
Reticulocyte Production Index (RPI)
-
Reticulocyte Production Index by a Single Equation
-
Reticulocyte Hemoglobin Content
-
RBC-to-Reticulocyte Hemoglobin Concentration Ratio
-
Wintrobe's Formula for Red Cell Indices (MCV, MCH, MCHC)
-
Estimating Hematocrit from Hematologic Parameters
-
Red Cell Distribution Width (RDW)
-
Hemoglobin Correction for Altitude
-
Hematocrit to Hemoglobin Ratio and Hemoconcentration
-
Causes of a Dimorphic Red Blood Cell Volume Histogram
-
Osmotic Fragility
-
Thermal Fragility and Pyropoikilocytosis
-
Red Blood Cell Production at Steady State
-
Grading Severe Aplastic Anemia
-
Criteria of Kwong et al for Response to Therapy for a Patient with Pure Red Cell Aplasia
-
Aplastic Anemia Following Infectious Mononucleosis (Epstein-Barr Virus, EBV)
-
Aplastic Anemia Following an Episode of Viral Hepatitis
-
Hypoplastic or Aplastic Anemia Associated with a Thymoma
-
Clinical Features of Pure Red Cell Aplasia Associated with Epoetin Therapy
-
Pure Red Cell Aplasia Associated with Pregnancy
-
Factors of Yoshida et al Predicting Response of a Child with Aplastic Anemia to Immunosuppressive Therapy
-
Criteria of the Japanese Childhood Aplastic Anemia Study Group for Response to Therapy
-
Inherited Bone Marrow Failure Syndromes
-
Dyskeratosis Congenita (DC)
-
Myelophthisis
-
Trauma-Associated Bone Marrow Failure
-
Aplastic Anemia and Hairy Cell Leukemia (HCL)
-
Aplastic Anemia vs Hypoplastic Myelodysplasia
-
Drugs and Chemicals Associated with Aplastic Anemia
-
Distinguishing Aplastic Anemia from Disseminated Mycobacteriosis
-
Hemoglobin Electropheresis
-
Estimating the P50 for Hemoglobin from a Venous Blood Sample
-
Causes of an Elevated Hemoglobin F
-
Causes of an Elevated Hemoglobin A2
-
Causes of an Decreased Hemoglobin A2
-
Differential Diagnosis of a Markedly Elevated Level of Hemoglobin A2
-
Upper Limit of Hemoglobin F During Infancy
-
Acute Splenic Sequestration in Patients with Sickle Cell Disease
-
Model of Miller et al for Predicting the Risk of Severe Complications in a Child with Sickle Cell Disease
-
Risk Factors of Platt et al for Early Death in Patients with Sickle Cell Disease
-
Clinical Danger Signs for Acute Complications in a Patient with Sickle Cell Disease
-
Estimating the Pain Rate in a Patient with Sickle Cell Disease Using the Equation of Platt et al
-
1999 Indications of Steinberg for Starting and Continuing Hydroxyurea Therapy in a Patient with Sickle Cell Disease
-
Risk Factors Associated with Mortality in Patients from the Multicenter Study of Hydroxyurea in Sickle Cell Anemia
-
Criteria of Galloway and Harwood-Nuss for Admitting a Patient with a Sickle Cell Crisis
-
Features of Kato et al for the Syndrome of Hemolysis-Associated Endothelial Dysfunction in Sickle Cell Disease
-
Factors Identified by Ware et al Predicting the Fetal Hemoglobin Response to Hydroxyurea Therapy in Children with Sickle Cell Anemia
-
Predictors of Adverse Outcome in a Pediatric Patient with Sickle Cell Anemia from the Cooperative Study of Sickle Cell Disease
-
Factors of Ballas and Lusardi for Hospital Readmission in an Adult with Acute Sickle Cell Pain
-
Severity Classification of Painful Crises in Sickle Cell Disease
-
Clinical Features of Berger et al for Distinguishing a Vaso-Occlusive Crisis from Osteomyelitis in a Child with Sickle Cell Disease
-
Severity Index of Wali et al for a Child with Sickle Cell Disease (SCD)
-
Predictors of Wali et al for Preservation of Splenic Function in a Child with Sickle Cell Disease
-
The Various Types of Sickle Cell Crises (Acute Exacerbations)
-
Index of van den Tweel et al for Severity of Sickle Cell Disease (SCD) in a Pediatric Patient
-
Clinical Severity Rating for Categorizing Events in a Patient with Sickle Cell Anemia
-
Risk Factors of Lorch et al for Excess Mortality in an Adult with Sickle Cell Disease
-
Intensive Care Unit Anemia Score of Milbrandt et al
-
Screening for Hereditary Spherocytosis With MCHC and RDW
-
Clinical and Laboratory Findings of Hereditary Pyropoikilocytosis
-
Platelet Count Estimate from Peripheral Blood Smear
-
Manual Platelet Counts Using a Hemacytometer
-
EDTA-dependent Pseudothrombocytopenia and Platelet Satellitism
-
Residual Platelet Distribution Width in Thrombocytosis
-
Using the RBC to Platelet Ratio Method for Measuring the Platelet Count
-
Criteria of Gulati et al for Grading Platelet Satellitism
-
Causes of Secondary (Reactive) Thrombocytosis
-
Pseudothrombocytosis Associated with Cryoglobulinemia
-
Megakaryocytes in the Peripheral Blood
-
White Cell Count Estimate from Peripheral Blood Smear
-
Correction of WBC for Nucleated Red Blood Cells
-
In Vitro Pseudoleukopenia
-
Absolute Phagocyte Count (APC)
-
Pseudoleukocytosis
-
Monocyte-to-Lymphocyte Ratio in Granulomatous Diseases
-
Necrobiotic Granuloma
-
Leukocyte Alkaline Phosphatase Score
-
FAB Classification of the Myelodysplastic Syndromes
-
Bournemouth Score of Mufti et al and Prognosis for the Myelodysplastic Syndromes
-
Score of Sanz et al and Prognosis for the Myelodysplastic Syndromes
-
Score of Goasguen et al and Prognosis for the Myelodysplastic Syndromes
-
Score of Varela et al and Prognosis for the Myelodysplastic Syndromes
-
Additional Factors Affecting the Prognosis for the Myelodysplastic Syndromes
-
A Prognostic Score for Myelodysplasia Based on Bone Marrow Histopathology (Hannover Score)
-
Dusseldorf Score and Prognosis in Primary Myelodysplastic Syndromes
-
International Prognostic Scoring System (IPSS) to Predict Survival in the Myelodysplastic Syndromes
-
FPC Prognostic Score of Passmore et al for Pediatric Myelodysplasia
-
Pavia Score and Prognosis for the Myelodysplastic Syndrome
-
Prognostic Score of Onida et al for Patients with Chronic Myelomonocytic Leukemia (M.D. Anderson Prognostic Score, MDAPS)
-
Features of the 5q- Myelodysplastic Syndrome
-
Features of Refractory Cytopenia with Multilineage Dysplasia (RCMD)
-
Features of Refractory Anemia with Excess Blasts (RAEB) in the WHO Classification for Myelodysplasia
-
Features of Chronic Myelomonocytic Leukemia (CMML) in the WHO Classification of Myelodysplasia
-
Features of Juvenile Myelomonocytic Leukemia (JMML) in the WHO Classification of Myelodysplasia
-
Prognostic Factors for Patients with Juvenile Myelomonocytic Leukemia (JMML)
-
Prognostic System of Matsuda et al for Patients with Refractory Anemia
-
Discriminant Score of Castro-Malaspina et al for Children with Chronic Myelomonocytic Leukemia
-
Prognostic Index for Cytogenetics (PI Score) of Pfeilstocker et al for a Patient with Myelodysplasia
-
Modified Bournemouth Score of Worsley et al for Patients with Chronic Myelomonocytic Leukemia
-
The Lausanne-Bournemouth (LB) Score of Parlier et al for a Patient with Primary Myelodysplastic Syndrome
-
The Lille Scoring Score of Morel et al for a Patient with a Primary Myelodysplastic Syndrome
-
The Four Parameter Dysplasia Index (DI) of Tassin et al for Survival in a Patient with a Myelodysplastic Syndrome (Liege Score)
-
The Granulation Score (G-Score) for Neutrophils of Widell et al
-
The Percentage of Pelgeroid Polymorphs (ppp) of Widell et al
-
Bone Marrow Dysplasia Score of Widell et al in a Patient with Myelodysplasia
-
Hematologic and Cytogenetic Score of Toyama et al for a Patient with Myelodysplasia
-
Risk Score of Gatto et al for a Patient with the Myelodysplastic Syndrome (MDS)
-
Hematologic Features of a Myelodysplastic-like Syndrome in Copper Deficiency
-
Criteria of Cheson et al for Hematologic Improvement Following Therapy for a Myelodysplastic Syndrome (International Working Group to Standardize Response Criteria)
-
Criteria of Cheson et al for Disease Progression or Relapse After Hematologic Improvement Following Therapy for Myelodysplastic Syndrome (International Working Group to Standardize Response Criteria)
-
Criteria of Cheson et al for Complete or Partial Remission After Therapy for Myelodysplastic Syndrome (International Working Group to Standardize Response Criteria)
-
Prognostic Model of Ribera et al for a Patient with Chronic Myelomonocytic Leukemia (CMML)
-
Prognostic Groups of Tennant et al for Patients with Myelodysplasia
-
Criteria of Cheson et al for Cytogenetic Response Following Therapy for a Myelodysplastic Syndrome (International Working Group to Standardize Response Criteria)
-
Recommendations of Estey for Therapy of Low Risk Myelodysplastic Syndrome (MDS) to Reduce the Need for Blood Transfusions
-
Model of Saunthararajah et al for Identifying a Patient with Myelodysplastic Syndrome Who Is Likely to Respond to Immunosuppressive Therapy
-
Prognostic Score of Malcovati et al for the Myelodysplastic Syndrome Using the WHO Classification (WHO Classification-Based Prognostic Scoring System, WPSS)
-
The Category, Cytology, Cytogenetics (CCC) System of Mandel et al for Classifying Pediatric Myelodysplasia
-
Simplified Myelodysplastic Syndrome Risk Score of Kantarjian et al
-
Idiopathic Cytopenia of Undetermined Significance (ICUS)
-
Minimal Diagnostic Criteria of Valent et al for Myelodysplastic Syndrome (MDS)
-
Modified International Prognostic Scoring System (IPSS) of Germing et al That Includes the Serum LDH in a Patient with a Myelodysplastic Syndrome (MDS)
-
Myelodysplasia in a Patient with Down's Syndrome
-
Prognostic Importance of Absolute Eosinophilia or Basophilia Associated with Myelodysplasia
-
Prognostic Score of Garcia-Manero et al for a Patient with Lower Risk Myelodysplastic Syndrome (LR-PSS)
-
Myelodysplastic Changes in a Patient with Visceral Leishmaniasis (Kala Azar)
-
Myelodysplasia with Marrow Fibrosis
-
Prognostic Model of Naqvi et al for a Patient with the Myelodysplastic Syndrome
-
Vitamin B12-Responsive Pancytopenia Causing Pseudo-Myelodysplasia
-
Flow Cytometric Score of Wells et al for the Myelodysplastic Syndrome: Myeloid Abnormalities Subscore
-
Flow Cytometric Score of Wells et al for the Myelodysplastic Syndrome: Monocytic Abnormalities Subscore
-
Flow Cytometric Score of Wells et al for the Myelodysplastic Syndrome: Final Score
-
Comprehensive Cytogenetic Scoring System of Schanz et al for Primary Myelodysplastic Syndrome or Oligoblastic Acute Myeloid Leukemia
-
Simplified MDS Risk Score of Gonzalez-Porras et al
-
Prognostic Score of Tong et al for Hypocellular Myelodysplastic Syndrome
-
Normal Cellularity for the Bone Marrow Biopsy
-
Iron Staining in the Bone Marrow Biopsy
-
Reticulin in the Bone Marrow Biopsy
-
Hazards Associated with Collection of Bone Marrow from the Sternum
-
Differential Diagnosis of Pseudo-Gaucher Cells in the Bone Marrow
-
Differential Diagnosis of Sea Blue Histiocytes in the Bone Marrow
-
Gelatinous Marrow Transformation (GMT, Serous Fat Atrophy, Starvation Marrow)
-
Causes of a Dry Bone Marrow Aspirate
-
Criteria of Thiele et al for Grading Myelofibrosis (MF)
-
Method of Curtin et al for Estimating the Nucleated Red Blood Cell Count of a Newborn Infant at Birth Based on Histologic Examination of the Placenta
-
Prognostic Significance of Nucleated Red Blood Cells (NRBCs) for a Patient in the Intensive Care Unit
-
Causes of Increased Numbers of Nucleated Red Blood Cells in a Newborn Infant
-
Absolute Nucleated Red Blood Cell Count
-
Body Fluid Cell Counts Using a Hemocytometer
-
Distinguishing Transudate vs Exudate in Pleural, Pericardial and Peritoneal Fluids
-
Distinguishing Urine from Ascitic or Pleural Fluid
-
Distinguishing Amniotic Fluid from Urine
-
Distinguishing Chylous from Pseudochylous (Chyliform, Cholesterol) Effusions
-
Cell Count and Cytocentrifuge Preparation for a Body Fluid
-
Prognostic Factors in Systemic Mast Cell Disease
-
Score of Travis et al for Predicting Survival in Patients with Systemic Mast Cell Disease
-
Consensus Classification for Mastocytosis
-
WHO Criteria for Systemic Mastocytosis
-
"B" and "C" Findings in Patients with Systemic Mastocytosis
-
WHO Criteria for Nonmalignant Variants of Systemic Mastocytosis
-
WHO Criteria for Mast Cell Leukemia
-
WHO Criteria for Mast Cell Tumor (Mastocytoma)
-
WHO Criteria for Cutaneous Mastocytosis, Including Urticaria Pigmentosa
-
Clinical and Laboratory Findings in a Patient with a Mast Cell Disorder
-
Criteria of Akin et al for Mast Cell Activation Syndrome (MCAS)
-
Response Criteria Following Therapy in a Patient with Cutaneous Mastocytosis
-
Grading Mastocytosis in the Skin (MIS) Symptoms
-
Grading Gastrointestinal Symptoms Associated with Mastocytosis
-
Serum Viscosity
-
Hematocrit and Whole Blood Viscosity
-
Equation of Shohat et al for Whole Blood Viscosity in a Neonate with Polycythemia
-
Algorithm of Slap et al for When to Biopsy an Enlarged Peripheral Lymph Node in a Young Patient
-
Recommendations for When to Biopsy an Enlarged Lymph Node
-
Solbiati Index (L to T Ratio) for the Sonographic Examination of a Lymph Node
-
Eggshell Calcification in Hilar and Mediastinal Lymph Nodes
-
Tattoo Pigment Lymphadenopathy
-
Criteria of Raut et al for a Sentinel Lymph Node
-
Infectious Granulomatous Lymphadenitis
-
Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease, KFD)
-
Argyrophilic Inclusion Positive and Pocked Erythrocyte Counts
-
Sonographic Biometry of Spleen Size in Childhood
-
Grades of Hackett for Splenomegaly Based on the Clinical Examination
-
Normal Splenic Length in Infants and Children Based on the Study of Rosenberg et al
-
Criteria for Hematologic Response to Splenectomy in a Patient with Suspected Sequestration
-
Evaluation of a Patient For Residual Splenic Tissue Following Splenectomy
-
Evaluation of a Patient with Howell-Jolly Bodies in the Peripheral Blood Smear
-
Criteria for Pathologist Review of Peripheral Blood Smears
-
Features of a Leukoerythroblastic Reaction
-
Evaluation of a Peripheral Blood Smear with Possible Schistocytes
-
Indications of Bain for a Clinician to Request an Examination of a Peripheral Blood Smear
-
Distinguishing an Echinocyte (Burr Cell) from an Acanthocyte in a Peripheral Blood Smear
-
Amorphous Blobs in the Peripheral Blood Smear
-
Rouleaux
-
Selenoid (Crescent) Bodies Within Erythrocytes
-
Criteria of Gulati for Grading Hypersegmentation of Neutrophils in a Peripheral Blood Smear
-
Criteria of Gulati for Grading Toxic Vacuoles within Neutrophils
-
Criteria of Gulati for Grading Toxic Granulation within Neutrophils
-
Criteria of Gulati for Grading the Number of Dohle Bodies within Neutrophils
-
Grading the Severity of Schistocytosis
-
Appearance of Erythrocytes in Pyropoikilocytosis
-
Heinz Bodies in Erythrocytes
-
Albumin Smear for Smudge Cells
-
Algorithm of Kiss et al for Evaluation of a Patient with Microcytic Anemia for Thalassemia
-
Diagnostic Algorithm of Lafferty for Thalassemia
-
Genetic Factors of Rund and Rachmilewitz Affecting a Patient with Beta-Thalassemia
-
Common Clinical Syndromes in Beta-Thalassemia
-
Risk Factors of Lucarelli et al Affecting Outcome for a Patient with Thalassemia Who Has Undergone Bone Marrow Transplantation
-
Acquired Thalassemia in Myeloproliferative or Myelodysplastic Disorders
-
Anemia of Chronic Disease
-
Cardio-Renal Anemia (CRA) Syndrome
-
Hepcidin in Anemia of Chronic Disease
-
Heart Failure-Associated Anemia
-
Prediction Rules of Ludwig for Response to Erythropoietin in a Patient with Cancer and Chronic Anemia
-
Criteria for Response for Erythropoietin (Epoetin) in a Cancer Patient
-
Evaluating a Patient Who Has Failed to Respond to Erythropoietin
-
Predictors of Stenke et al for the Response to Erythropoietin in a Patient with a Myelodysplastic Syndrome
-
Pure Red Cell Aplasia Associated with the Use of Recombinant Erythropoietin
-
Predictive Factors of Musto et al for a Response to Darbepoetin alpha in a Patient with a Low-to-Intermediate Risk Myelodysplastic Syndrome
-
Score of Hellstrom-Lindberg for Predicting Response to Erythropoietin Plus Granulocyte Colony Stimulating Factor in an Anemic Patient with Myelodysplasia
-
Evaluation of the Patient with Increased MCV but Normal Serum Folate and Vitamin B12 Levels
-
Masked Megaloblastic Anemia
-
Failure of Megaloblastic Anemia to Respond to Vitamin Replacement Therapy
-
Causes of Drug-Induced Megaloblastosis
-
Imerslund-Graesbeck Syndrome (Hereditary Megaloblastic Anemia Type 1)
-
Clinical Classes of Glucose-6-Phosphate Dehydrogenase (G6PD) Enzyme Variants
-
Risk Factors for Acute Hemolysis in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
-
Clinical Features of an Acute Hemolytic Episode After Fava Bean Ingestion in a Patient with Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (Favism, Fava Crisis)
-
Criteria of the International Agranulocytosis and Aplastic Anemia Study for Agranulocytosis (IAAAS)
-
Criteria for the Diagnosis of Drug-Induced Agranulocytosis
-
Clinical and Laboratory Features of Cyclic Neutropenia
-
Prognostic Factors of Julia et al for a Patient with Drug-Induced Agranulocytosis
-
Clinical and Laboratory Features of Drug-Induced Agranulocytosis
-
Differential Diagnosis of Neutropenia in an HIV-Infected Patient
-
Normal White Blood Cell Count Agranulocytosis
-
Implications of Dose and Response to Long-Term Granulocyte Colony Stimulating Factor (G-CSF) in a Patient with Severe Congenital Neutropenia
-
Algorithm for Classification of Anemia Based on Red Blood Cell Indices and the Reticulocyte Count
-
Classification of Bessman et al for Anemia Based on MCV and RDW
-
Classification of Anemia Based on Mechanism
-
Risk Factors for Anemia in Patients with HIV Disease
-
Diagnostic Approach of Moore and Forney for Anemia in HIV-Infected Patients
-
Risk Factors of Bani-Sadr et al for Anemia in a Patient Coinfected with HIV and HCV
-
Management of a Patient with Eisenmenger Syndrome and Erythrocytosis
-
Clinical Features of Hyperviscosity in Erythrocytosis
-
Erythrocytosis (Polycythemia) Associated with Androgens and Steroid Hormones
-
Erythrocytosis Following Renal Transplantation (Post-Renal Transplantation Erythrocytosis)
-
Risk Factors for Neonatal Polycythemia
-
Management Algorithm of Jeevasankar et al for Neonatal Polycythemia
-
Secondary Erythrocytosis in Patients Treated with a Tyrosine Kinase Inhibitor (TKI)
-
Clinical Findings of Myeloperoxidase Deficiency in Neutrophils
-
Clinical Finding of Classic Chronic Granulomatous Disease (CGD) with Pediatric Onset
-
Clinical Findings of Chronic Granulomatous Disease (CGD) Diagnosed in the Adult
-
Clinical Findings Suggesting a Hereditary Leukocyte Adhesion Deficiency (LAD)
-
Conditions Associated with Acquired Defects in Neutrophil Function
-
Indications for Evaluating a Patient for Inherited Defects in Macrophage Function (Inherited Susceptibility to Mycobacteria and Salmonella)
-
Postural Pseudoanemia
-
Differential Diagnosis of Ross et al for Hematologic Disorders in a Patient with a Systemic Vasculitis
-
Risk Factors of Hung et al for Anemia Associated with Antiviral Therapy in a Patient with Viral Hepatitis C
-
Risk Factors for Bone Marrow Suppression in a Patient Receiving Low Dose Methotrexate
-
Indications to Test a Patient for Paroxysmal Nocturnal Hemoglobinuria
-
Laboratory Features of the Classic and Hypoplastic PNH Phenotypes
-
Red Blood Cell Phenotype Mosaicism in Paroxysmal Nocturnal Hemoglobinuria (RBC Types)
-
Laboratory Screening of a Patient with Suspected Paroxysmal Nocturnal Hemoglobinuria
-
Prognostic Factors of Socie et al Affecting Survival in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
Prognostic Factors of Nishimura et al for a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
Signs and Symptoms Associated with Smooth Muscle Dystonia in Paroxysmal Noctural Hemoglobinuria (PNH)
-
Distinguishing Classic Paroxysmal Nocturnal Hemoglobinuria (PNH) from Aplastic Anemia
-
Hemolytic Anemia Following Heavy Alcohol Use (Zieve Syndrome)
-
Microangiopathic Hemolytic Anemia
-
Criteria of Ruutu et al for Hematopoietic Stem Cell Transplant-Associated Microangiopathy
-
Risk Factors for Hematopoietic Stem Cell Transplant-Associated Microangiopathy (TAM)
-
Spur Cell Anemia in a Patient with Liver Disease
-
Criteria of Ho et al for Transplant-Associated Thrombotic Microangiopathy (TA-TMA, BMT-CTN Criteria)
-
Passenger Lymphocyte Syndrome (PLS) with Immune Hemolytic Anemia (Humeral Graft-vs-Host Reaction) in a Transplant Recipient
-
Intravascular Hemolysis Secondary to Acute Pancreatitis
-
Conditions Associated with Benign Nonhepatosplenic Extramedullary Hematopoiesis
-
Clinical Findings Associated with Benign Nonhepatosplenic Extramedullary Hematopoiesis
-
Clinical and Pathologic Findings in Pulmonary Extramedullary Hematopoiesis
-
Causes of Splenosis
-
Locations and Distribution of Splenic Tissue in Splenosis
-
Locations for an Accessory Spleen
-
Classification of Losanoff et al for Nonparasitic Splenic Cysts
-
Classification of Morgenstern for Nonparasitic Splenic Cysts
-
Criteria of Morgenstern for Nonoperative Management of a Nonparasitic Splenic Cyst
-
Causes of Nontraumatic Rupture of the Spleen
-
Criteria for the Diagnosis of Spontaneous Splenic Rupture
-
Clinical Features of a Ruptured Spleen
-
Risk Factors for Complications Associated with a Splenic Aspirate
-
Factors Affecting the Likelihood That a Splenic Aspirate Will Provide Useful Information
-
Diagnosis of Hypersplenism
-
The Wandering and Pelvic Spleen
-
Pleural Splenosis (Thoracic Splenosis)
-
Clinical Findings in a Patient with the Hypereosinophilic Syndrome
-
Criteria for the Diagnosis of Chronic Eosinophilic Leukemia (CEL)
-
Criteria for the Diagnosis of Idiopathic Hypereosinophilic Syndrome (HES)
-
Tropical Eosinophilia (Tropical Pulmonary Eosinophilia)
-
Differential Diagnosis of Eosinophilia
-
Anemia of Prematurity
-
Microcytic Anemia Associated with Aluminum Poisoning
-
Hemolytic Anemia Associated with Lead Poisoning
-
Peripheral Blood Findings in Hemoglobin CC (Spherocytes and Target Cells)
-
Clinical and Laboratory Features of Hemoglobin SOarab
-
Hereditary Persistence of Hemoglobin F (HPHF)
-
Evaluation of a Patient with Hemoglobin S and Elevated Hemoglobin F
-
Paraneoplastic Production of Hemoglobin F
-
Microcytosis Associated with Hemoglobin E Trait
-
Thymic Hyperplasia (Thymic Rebound) Causing a False Positive PET Scan Following Chemotherapy
-
Differential Diagnosis of an Elevated Mean Corpuscular Hemoglobin Concentration (MCHC)
-
Impact of Plasma Osmolality on the Spun Hematocrit
-
Pseudothrombocytopenia Due to a Platelet Cold Agglutinin
-
Revised International Prognostic Scoring System (IPSS-R) of Greenberg et al
-
Prognostic Score of Itzykson et al for a Patient with Chronic Myelomonocytic Leukemia (CMML)
-
Prognostic Score of Itzykson et al for a Patient with Higher Risk Myelodysplasia Treated with Azacitidine
-
Ring Sideroblasts of Sideroblastic Anemia
-
Luetic Lymphadenitis (Syphilitic Lymphadenopathy)
-
Clues to Sideroblastic Anemia in the Peripheral Blood Smear
-
Algorithm of Mogensen et al for Diagnosing Anemia in a Small Child in an Area of Rural Tanzania Endemic for Malaria
-
Differential Diagnosis of Microcytic Anemia
-
Chuvash Polycythemia
-
Somatic Mutations of Bejar et al Associated with Poor Outcome for a Patient with the Myelodysplastic Syndrome Undergoing Hematopoietic Stem Cell Transplantation
-
Normalizing Splenic Volume for Weight and Body Surface Area
-
Basophilic Stippling
-
Agranular and Hypogranular Platelets
-
Anemia of Infection
-
Differential Diagnosis of Anemia in a Patient with Infection
-
Thiamine-Responsive Megaloblastic Anemia (TRMA) with Diabetes Mellitus and Sensorineural Deafness Associated with Mutations in SLC19A2
-
Neonatal Alloimmune Neutropenia (NAIN, Isoimmune Neonatal Neutropenia)
-
Clozapine-Associated Neutropenia and Agranulocytosis
-
Differential Diagnosis of Neutropenia in a Neonate
-
Neonatal Neutropenia Secondary to Maternal Pregnancy-Induced Hypertension
-
Delayed Hemolysis After Parenteral Artesunate Therapy for Malaria (Postartemisinin Delayed Hemolysis, PADH)
-
Causes of Sideroblastic Anemia
-
Sickle Cell Abdominal Vaso-Occlusive Crisis (Sickle Cell Girdle Syndrome, Sickle Cell Ischemic Colitis)
-
Impact of Fatigue on Overall Survival for a Patient with Myelodysplastic Syndrome
-
Differential Diagnosis of Granulomas in the Bone Marrow
-
Significance of Nucleated Red Blood Cells (Erythroblasts) in the Peripheral Blood Smear of a Patient Who is Critically Ill
-
Risk Factors of Teawtrakul et al for Severe Infection in a Patient with Non-Transfusion-Dependent Thalassemia
-
Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Hematologic and Iron Status
-
Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Liver and Gallbladder Status
-
Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Cardiovascular Status
-
Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Comorbid Conditions
-
Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Pediatric Patient
-
Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Total Score
-
Algorithm of Gibson and Berliner for Evaluating an Adult with Neutropenia
-
Sarcoidosis of the Bone Marrow
-
Categories of de Latour for a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
Equation of Chandra et al for Distinguishing Beta-Thalassemia Minor from Iron Deficiency Anemia
-
Impact of Smoking on Hemoglobin Concentrations from the World Health Organization (WHO)
-
Risk Assessment Tool of Bernard et al for a Patient with Sickle Cell Disease in the Emergency Department
-
Score of Glassberg et al for Predicting 30-Day ED Revisit for Pain in a Patient with Sickle Cell Anemia
-
Prognostic Score of Shaffer et al for a Patient with Myelodysplasia Undergoing an Allogeneic Hematopoietic Cell Transplant
-
Therapy-Related Myelodysplastic Prognostic Scoring System of Quintas-Cardama et al
-
Flow Cytometry Score of Ahlan et al for a Patient with Myelodysplastic Syndrome (MDS)
-
Equation of de Simone et al for Whole Blood Viscosity (WBV)
-
World Health Organization (WHO) Classification of Anemia Severity Based on Hemoglobin
-
Risk Factors of Brodsky et al for 30-Day Readmission for an Adult with Sickle Cell Disease and Vaso-Occlusive Pain
-
Criteria of Abou-Elhamd for the Laboratory Diagnosis of Sickle Cell Disease
-
Score of Bartolucci et al for Predicting the Acute Chest Syndrome During a Sickle Cell Vaso-Occlusive Crisis
-
2014 Recommendations of the NHLBI Expert Panel for Starting and Continuing Hydroxyurea Therapy in a Patient with Sickle Cell Anemia (SCA)
-
Anemia of Thermal Injury (Anemia of Burns)
-
Indication for a Bone Marrow Trephine Biopsy
-
Adequacy of a Bone Marrow Biopsy in a Pediatric Patient
-
Criteria of Hartung et al for Response to Therapy in a Pediatric Patient with Acquired Aplastic Anemia
-
Mahidol Score of Sripichai et al for beta-Thalassemia/Hemoglobin E Disease
-
Phenotype Score of Phadke and Agarwal for Thalassemia Intermedia
-
Criteria of Weatherall for Non-Transfusion-Dependent (NTD) Thalassemia
-
Congenital Dyserythropoietic Anemia Type I (CDAI)
-
Congenital Dyserythropoietic Anemia Type II (CDA II, HEMPAS)
-
Congenital Dyserythropoietic Anemia Type III (CDA III)
-
Congenital Dyserythropoietic Anemia Type IV (CDA IV)
-
GATA-1 X-Linked Thrombocytopenia With or Without Dyserythropoietic Anemia (XLTDA)
-
False Positive and False Negative Diagnosis of Anemia
-
Extramedullary Hematopoiesis as Tumor Mass
-
AAPT Criteria for the Diagnosis of Chronic Sickle Cell Disease Pain
-
Model of Chaturvedi et al for Sickle Cell Disease Based on FEV1 and Tricuspid Regurgitant Jet Velocity
-
Differential Diagnosis of Absolute Lymphocytopenia (Lymphopenia)
-
Differential Diagnosis of Absolute Lymphocytosis
-
Screening Criteria of Andrews et al for Lymphocytosis with an Abnormal Immunophenotype
-
Persistent Polyclonal B-Cell Lymphocytosis (PPBL)
-
Warning Signs for a Hematologic Malignancy in a Patient with an Unexplained Leukocytosis
-
Differential Diagnosis of Absolute Basophilia
-
Risk Factors of Poesen et al for Anemia in the First Three Months After a Renal Transplant
-
Risk Factors of Butwick et al for Postpartum Anemia After Cesarean Section
-
Time to Reversal of Anemia After Blood Donation (Time to Hemoglobin Recovery in a Blood Donor)
-
Transient Erythroblastopenia of Childhood (TEC)
-
Correction of Hemoglobin Concentrations for Altitude from the World Health Organization (WHO)
-
Causes of Stomatocytosis
-
Clinical and Laboratory Severity of Hereditary Spherocytosis
-
When to Suspect Hereditary Spherocytosis in a Child or Adult
-
Diagnosis of Hereditary Spherocytosis in a Neonate
-
Dehydrated Hereditary Stomatocytosis (Hereditary Xerocytosis)
-
Conditions Associated with Acanthocytes (Spur Cell Anemia, Neuroacanthocytosis)
-
Conditions Associated with Echinocytes (Burr Cells)
-
Overhydrated Hereditary Stomatocytosis
-
Rh Deficiency Syndrome (Rh Null and Rh Mod)
-
Eosin-5'-Maleimide (E5M) Flow Cytometry in Hereditary Spherocytosis
-
Mean Platelet Volume (MPV) and Prognosis for a Patient with Severe Infection
-
Risk Factors for Rapid Progression of Myelodysplasia (MDS) in a Patient with "Low Risk" IPSS
-
Refractory Cytopenia of Childhood (RCC)
-
Subtypes of Unclassifiable Myelodyplasia (MDS-U)
-
Volume of a Trephine Needle Core Bone Marrow Biopsy
-
Bone Marrow Edema
-
Bone Marrow Score of Wang et al for Identifying an Immunocompetent Patient with Fever of Unknown Origin (FUO) Who Should Have Bone Marrow Biopsy
-
Benign Signet Ring Histiocytes in Lymph Node Sinuses
-
Hematologic Features of delta-beta-Thalassemia Versus beta-Thalassemia and Iron Deficiency Anemia
-
Algorithm of Planche et al for Evaluating a Patient with Extreme Macrocytosis
-
Clinical and Laboratory Features of Red Cell Pyruvate Kinase Deficiency
-
Indications of Grace et al for Diagnostic Testing in a Patient with Suspected Red Cell Pyruvate Kinase Deficiency
-
Predictors of Grace et al for the Response to Splenectomy in a Patient with Red Cell Pyruvate Kinase Deficiency
-
Triggers for Hemolysis in Red Cell Pyruvate Kinase Deficiency
-
Anemia and Hypophosphatemia
-
Criteria of Jodele et al for Hematopoietic Stem Cell Transplant (HSCT) Associated Thrombotic Microangiopathy (TMA)
-
Hemolytic Anemia in Wilson's Disease
-
Polysplenia Syndrome (Polysplenic Heterotaxy Syndrome)
-
Lymphocyte-Variant Hypereosinophilia
-
Prognostic Factors of Lefebvre et al for a Patient with Hypereosinophilia
-
Paraneoplastic Eosinophilia
-
Pediatric Thymic Hyperplasia
-
Thymic Hyperplasia and Graves' Disease (Thyrotoxicosis) With or Without Myopathy (Pseudo-Myasthenia Gravis)
-
Thymic Index of Hasselbalch et al
-
Equation of Hassalbalch et al for Predicting the Thymic Index of a Preterm Neonate
-
Equations of Hasselbalch et al for Estimating the Thymic Index in Infants
-
Conditions Associated with Eryoptosis
-
Differential Diagnosis of Noncaseating Granulomas
-
Mayo Score for Chronic Myelomonocytic Leukemia (CMML)
-
Adequacy of a Bone Marrow Collection in an Adult
-
Equations of Chow et al for Normal Values of Splenic Size
-
Erythropoietin Resistance Index (ERI, Erythropoiesis Stimulating Agent Resistance Index)
-
Risk Factors of de Lurdes Agostinho Cabrita et al for Erythropoiesis Stimulating Agent Resistance in Pre-Dialysis Chronic Kidney Disease
-
Cystatin C and Cardiovascular Dysfunction in Sickle Cell Disease
-
Modified WPSS (WHO Classification-Based Prognostic Scoring System) of Cermak et al
-
Model of Boutault et al to Screen for Myelodysplastic Syndrome in a Patient with Unexplained Cytopenia (MDS-CBC Score)
-
Criteria of Savona et al for Progression in Adult MDS/MPN
-
Transfusion Dependence in Myelodysplasia
-
Benign Mesothelial Cells in a Lymph Node (Mesothelial Lymph Node Inclusion)
-
Blood Smear Changes in Cryoglobulinemia
-
Causes of Anemia After Roux-en-Y Gastric Bypass Surgery
-
Autoimmune Myelofibrosis (AIMF)
-
Hemolytic Anemia Associated a Prosthetic Heart Valve
-
Differential Diagnosis of Microangiopathic Hemolytic Anemia Associated with Pregnancy
-
Unexplained Hematologic Disorders of the Elderly: Differential Diagnosis
-
Unexplained Hematologic Disorders of the Elderly: Idiopathic Cytopenia of Unknown Significance (ICUS)
-
Unexplained Hematologic Disorders of the Elderly: Clonal Cytopenia of Unknown Significance (CCUS)
-
Unexplained Hematologic Disorders of the Elderly: Idiopathic Dysplasia of Unknown Significance (IDUS)
-
Unexplained Hematologic Disorders of the Elderly: Clonal Hematopoiesis of Indeterminate Potential (CHIP)
-
Iron Deficiency Anemia Associated with Hereditary Hemorrhagic Telangiectasia (HHT)
-
Absolute Reticulocyte Count and the Differential Diagnosis of Pancytopenia
-
Differential Diagnosis of DeZern and Guinan for Pancytopenia in a Young Adult
-
Algorithm of Naessens et al for the Management of Hemoglobin SC Disease
-
Complications of Hemoglobin SC Disease
-
Predictive Factors of Silva et al for Adverse Outcomes in a Child with Sickle Cell Disease
-
Risk Factors of Belisario et al for Intracerebral Changes in a Neonate with Sickle Cell Anemia
-
Markers of Brousse et al for Disease Severity in Infants with Sickle Cell Anemia
-
Hypoxia Associated with Right-to-Left Shunt in a Patient with Sickle Cell Anemia
-
Cardiac Abnormalities in a Patient with Sickle Cell Anemia
-
Vascular High-Risk Profile of Nouraie et al in a Patient with Sickle Cell Anemia
-
Cerebral Fat Emboli (CFE) in Patients with Sickle Cell Disease
-
Clinical Findings Associated with the Acute Chest Syndrome Associated with Sickle Cell Disease
-
Precipitating Factors for the Acute Chest Syndrome in a Patient with Sickle Cell Disease
-
Findings of Alkindi et al in a Patient with Sickle Cell Disease That Are Associated with Acute Chest Syndrome (ACS)
-
Hereditary Spherocytosis and the MCHC-to-MCV Ratio (Neonatal HS Index)
-
Conditions Associated with Decreased Eryoptosis
-
Marked Lymphocytosis Associated with Cytomegalovirus (CMV) Infection
-
Prognostic Significance of Monocytosis in Myelodysplasia
-
Prognostic Score of Liu et al for Unclassifiable Myelodysplastic Syndrome
-
Prognostic Factors of Germing et al for a Patient with Chronic Myelomonocytic Leukemia (CMML)
-
Prognostic Score of Gonzalez-Medina et al for Chronic Myelomonocytic Leukemia (CMML)
-
Cytogenetic Risk Stratification of Such et al for Chronic Myelomonocytic Leukemia (CMML)
-
Chronic Myelomonocytic Leukemia (CMML) Specific Prognostic Scoring System (CPSS) of Such et al
-
Chronic Myelomonocytic Leukemia Specific Prognostic Scoring System of Elena et al (CMML CPSS-mol)
-
Bedside Risk Categories of Tefferi et al for a Patient with a Myelodysplastic Syndrome (MDS)
-
MastFx Score of van der Veer et al for Predicting Fragility Fractures Associated with Indolent Systemic Mastocytosis (ISM)
-
Anaphylaxis Risk Assessment Tool of Gulen et al for a Patient with Systemic Mastocytosis
-
NIH Idiopathic Clonal Anaphylaxis Score (NICAS) of Carter et al
-
Equation of Prassopoulos et al for Splenic Volume in Adults
-
Pappenheimer Bodies
-
Target Cells (Codocytes)
-
Cabot Rings
-
Teardrop Cells (Dacrocytes)
-
Leptocytes (Wafer Cells)
-
Bite Cells
-
Blister Cell
-
Neutrophilic Changes Associated with Bacterial Infection
-
Anemia Associated with Scurvy
-
ITACA Score of Buckstein et al for Response to an Erythropoietic Stimulating Agent in a Patient with Myelodysplasia
-
Differential Diagnosis of Neutropenia Associated with Infectious Mononucleosis
-
Neutropenia Associated with Large Granular Lymphyocytes
-
Differential Diagnosis of a Macrocytic or Megaloblastic Anemia
-
Differential Diagnosis of Normocytic Anemia
-
Causes of Hemolytic Anemia
-
Differential Diagnosis of Hemolytic Anemia in a Neonate
-
Conditions Associated with Splenic Infarction
-
Algorithm of Patnaik and Tefferi for Evaluating a Patient with Ring Sideroblasts
-
Differential Diagnosis of Congenital Sideroblastic Anemia
-
Refractory Anemia with Ringed Sideroblasts and Thrombocytosis (RARS-T, Myelodysplastic/Myeloproliferative Neoplasm with Ringed Sideroblasts and Thrombocytosis, MDS/MPN-RS-T)
-
Prognostic Score of Patnaik et al for Refractory Anemia with Ringed Sideroblasts and Thrombocytosis (RARS-T, Myelodysplastic/Myeloproliferative Neoplasm with Ringed Sideroblasts and Thrombocytosis, MDS/MPN-RS-T)
-
Equation of Matos et al for Distinguishing Iron Deficiency Anemia from Thalassemia Trait (Matos and Carvalho Index)
-
RDW Index (RDWI) of Jaybose et al for Differentiating Iron Deficiency Anemia from Thalassemia Trait
-
Index of Ehsani et al for Discrimination Between Iron Deficiency Anemia and Beta-Thalassemia Minor
-
Equation of Sirdah et al for Distinguishing Iron Deficiency Anemia from Beta Thalassemia Minor
-
Pancytopenia Associated with Severe Anorexia Nervosa
-
Mean Platelet Volume (MPV) to Lymphocyte Ratio (MPVLR)
-
Mean Platelet Volume to Platelet Count Ratio (MPV to PC Ratio)
-
Ratio of Platelet Distribution Width (PDW) to Platelet Count
-
White Blood Cell Count to Mean Platelet Volume (MPV) Ratio (WMR)
-
Leukemoid Reaction
-
Predictors of Nomdedeu et al for Excess Mortality in a Patient with Myelodysplastic Syndrome
-
Risk Score of Shi et al for a Patient with Myelodysplasia
-
Clinical Prognostic Score of Starkman et al for a Patient with the Myelodysplastic Syndrome (MDS)
-
Complication Risk Scores of Vitrano et al for a Patient with Thalassemia: Transfusion-Dependent Thalassemia (TDT)
-
Complication Risk Scores of Vitrano et al for a Patient with Thalassemia: Transfusion-Dependent Thalassemia (NTDT) Patients Receiving Transfusions
-
Complication Risk Scores of Vitrano et al for a Patient with Thalassemia: Non-Transfusion-Dependent Thalassemia (NTDT) Not Receiving Transfusion
-
Screening Criteria of Samavat for Beta-Thalassemia Minor
-
Model of Santini et al for Predicting Response to Erythropoietic-Stimulating Agents with IPSS Low or Intermediate-1 Risk Myelodysplasia
-
Congenital Neutropenia Due to G3PC3 Deficiency Including Dursun Syndrome
-
Hemogram Pattern Associated with a Cold Agglutinin
-
Anemia Associated with Cadmium Intoxication
-
CT Grading Scale of McCune et al for Thymic Size
-
X-Linked Sideroblastic Anemia and Cerebellar Ataxia (XLSA/A) Associated with Mutations in ABC7 (ABCB7)
-
X-Linked Sideroblastic Anemia Associated with Mutations in ALAS2
-
Myopathy, Lactic Acidosis and Sideroblastic Anemia (MLASA)
-
Congenital Sideroblastic Anemia Associated with Mutations in GLRX5
-
Congenital X-Linked Sideroblastic Anemia Associated with Mutations in NDUFB11
-
Congenital Sideroblastic Anemia Associated with Mutations in SLC25A38
-
Phenotypic Risk Score of Sachdev et al for Predicting Mortality in Sickle Cell Disease (PReMSCD)
-
Biomarkers of Nouraie et al for Risk of Mortality for a Young Patient with Sickle Cell Disease
-
Growth Failure in a Patient with Sickle Cell Anemia
-
Fat Embolism Syndrome in Sickle Cell Disease
-
Predictors of Kumar et al for 30-Day Readmission Following a Sickle Cell Crisis
-
Idiopathic CD4+ Lymphocytopenia (ICL)
-
M.D. Anderson Lower-Risk Prognostic Scoring System (LR-PSS, LR-MDAS) for a Patient with Myelodysplasia
-
Myelodysplastic Syndrome Associated with Mutations in SF3B1
-
Mutation-Augmented Prognostic Scoring System (MAPSS) of Pardanani et al for Advanced Systemic Mastocytosis
-
REMA Score of Alvarez-Twose et al for Systemic Mast Cell Activation Disorder (MCAD)
-
Jordans' Anomaly (Cytoplasmic Lipid Droplets in Granulocytes)
-
Thyrotoxicosis-Induced Anemia
-
Anemia in Crohn's Disease
-
Differential Diagnosis of Severe Congenital Neutropenia (SCN)
-
Investigation of Neutropenia in a Patient with Neutropenia
-
Rules of Yefet et al for Avoiding Iron Deficiency Anemia in a Pregnant Woman at the Time of Delivery
-
Anemia Associated with Geophagia and Other Forms of Pica
-
Index of Brewin et al for Ineffective Erythropoiesis (IoIE) in Sickle Cell Disease
-
Extreme Hyperbilirubinemia in Sickle Cell Disease
-
Red Flags of Cisewski for Evaluating a Patient with Sickle Cell Disease in the Emergency Department
-
Brown Fat in the Bone Marrow
-
Predictors of Simsek for Mortality After Non-Traumatic Splenectomy
-
Prognostic Score of Khirallah et al for a Pediatric Patient Undergoing Splenectomy for a Benign Hematological Disorder
-
Grading Score of Luppi et al for Technical Difficulty of a Laparoscopic Splenectomy for a Non-Traumatic Disorder (Difficulty Score)
-
Score of Liu et al for Predicting Difficulty of Laparoscopic Splenectomy for a Non-Traumatic Disease
-
Predictive Factors of Nyilas et al for Laparoscopic Splenectomy for Immune Thrombocytopenic Purpura (ITP)
-
Partial Splenectomy
-
Screening Criteria of Ambayya et al to Distinguish Between Alpha and Beta Thalassemia Traits
-
Predictors of Kamperidis et al for Long-Term Survival in a Transfusion-Dependent Patient with Thalassemia
-
Score of Xu et al for a Patient with Aplastic Anemia Following a Haploidentical Allogeneic Hematopoietic Stem Cell Transplant (Haplo-HSCT Scoring System)
-
The Sickling Hemoglobinopathies
-
Mast Cell Activation Syndrome (MCAS) in a Patient with Sickle Cell Disease
-
Barriers to the Use of Hydroxyurea in a Pediatric Patient with Sickle Cell Anemia
-
Impact of HIV on the Prognosis of Myelodysplastic Syndrome (MDS)
-
Risk Stratification Score of Hou et al for a Patient with the Myelodysplastic Syndrome
-
Benign Ethnic Neutropenia (BEN)
-
Autoimmune Neutropenia
-
Childhood Neutropenia in PAMI
-
Genetic Causes of Chronic Granulomatous Disease (CGD)
-
Differential Diagnosis of Anemia in Chronic Granulomatous Disease (CGD)
-
Hemophagocytic Lymphohistiocytosis (HLH) Reactions in Chronic Granulomatous Disease (CGD)
-
Prognostic Factors of Virk et al for a Patient with Spur Cell Hemolytic Anemia (SCHA) Associated with End-Stage Liver Disease
-
Splenic Peliosis
-
Splenic Torsion and the Wandering Spleen
-
CT Manifestations of Splenic Torsion
-
Unstable Hemoglobinopathies (Congenital Heinz Body Hemolytic Anemia)
-
Congenital Methemoglobinemia
-
Equations of Xiao et al for Distinguishing Thalassemia Traits from Iron Deficiency Anemia in a Pregnant Woman
-
Pancytopenia Associated with Cannabis Use
-
Pancytopenia in a Patient with Graves' Disease
-
Pancytopenia with Myelodysplastic Features in Chronic Arsenic Poisoning
-
Features of Iwasaki et al for Distinguishing Aplastic Anemia from Myelodysplastic Syndrome
-
Predictors of Zaimoku et al for Response of a Patient with Aplastic Anemia to Therapy
-
Score of Olupot-Olupot et al for Screening a Sick Child in Africa for Sickle Cell Anemia
-
Nutritional Indices in Patients with the Myelodysplastic Syndrome
-
Genomic Groups of Bersanelli et al for Myelodysplastic Syndromes
-
Prognostic Significance of Hemoglobin F in Patients with Myelodysplastic Syndrome
-
CMML Transplant Score of Gagelmann et al for a Patient with CMML
-
Chronic Myelomonocytic Leukemia (CMML) Variants
-
Prognostic Score of Patnaik et al for a Patient in CMML
-
Use of Serum Ferritin and Age to Evaluation a Patient with Transfusion-Dependent Thalassemia for Iron Overload
-
Thalassemia International Prognostic Scoring System (TIPSS)
-
Grading Myocardial Iron Overload (MIO) in Transfusion-Dependent Thalassemia
-
Grading Hepatic Iron Overload (HIO) in Transfusion-Dependent Thalassemia
-
Equations of Hayreh et al for Estimating the Upper Limit of Normal for the Erythrocyte Sedimentation Rate (ESR)
-
Equation of Sirachainan et al for Differentiating Thalassemia Trait from Iron Deficiency Anemia
-
Iron Deficiency Anemia in Inflammatory Bowel Disease (IBD, Crohn's Disease, Ulcerative Colitis)
-
Early Death Risk Score Model of Liu et al for a Patient with Severe Aplastic Anemia
-
Factitious Aplastic Anemia
-
Index of Ineffective Erythropoiesis (IoIE)) as Measure of Ineffective Erythropoiesis in Sickle Cell Disease
-
Prognostic Factors of Qian et al for a Patient with Myelodysplasia
-
Pseudoreticulocytosis (Delayed Maturation of Reticulocytes) in Myelodysplasia
-
Study of Musallam et al for Predicting Survival of a Patient with Non-Transfusion Dependent Beta Thalassemia
-
Decisions in Erythropoietin Therapy in a Patient with Cancer
-
Hemolysis Associated with Fresh Water Near-Drowning (Drowning Hemoglobinuria)
-
Thal Index of Nishad et al
-
Equation of Bordbar et al for Distinguishing Beta-Thalassemia Minor from Other Microcytic Anemias
-
Model of Xu et al for Distinguishing Thalassemia Trait from Iron Deficiency Anemia
-
Hemoconcentration and Increase in Hematocrit
-
Predictors of Groarke et al for Clonal Evolution in a Patient with Severe Aplastic Anemia Receiving Immunosuppressive Therapy
-
Spontaneous Subgaleal Hematoma in a Patient with Sickle Cell Disease (Acute Soft Head Syndrome)
-
Mutated Gene Count of Nazha et al for a Patient with Myelodysplasia
-
Flow Cytometric (FCM) Score of Della Porta et al for the Diagnosis of Low-Grade Myelodysplasia
-
Myelodysplasia Cutis
-
Mutation Risk Score and the MIPSS-R of Gu et al for Risk Stratification of a Patient with Myelodysplasia
-
RED Score of Mathis et al for Diagnosis of Myelodysplasia By Flow Cytometry
-
Nomogram of Liang et al for Evaluating a Patient with Myelodysplastic Syndrome (MDS)